Article
Pneumothorax triggered by EGFR-tyrosine kinase inhibitors in three microwave ablation candidates: A review of the literature.
Thoracic cancer - 1 Jul 2020
Guo Runqi, Li Yuanming, Bie Zhixin, Li Bin, Li Xiaoguang
Abstract excerpt
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are widely used in patients with EGFR-mutant lung cancer. Meanwhile, thermal ablation such as microwave ablation has been an option for selected patients. Herein, we describe three cases of pneumothorax that occurred in microwave ablation (MWA) candidates treated with EGFR-TKIs. The three patients developed pneumothorax in different...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
